Vikas A. Gupta

The Nf2 Tumor Suppressor, Merlin, Functions in Rac-Dependent Signaling

Reuben J. Shaw, J. Guillermo Paez, Marcello Curto et al. · Developmental Cell · 2001 · 345 citations · Full text

Medicine, Molecular Biology, Oncology +14

Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma

Nisha S. Joseph, Jonathan L. Kaufman, Madhav V. Dhodapkar et al. · Journal of Clinical Oncology · 2020 · 237 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone

Timothy M. Schmidt, Benjamin G. Barwick, Nisha S. Joseph et al. · Blood Cancer Journal · 2019 · 165 citations · Full text

Medicine, Hematology, Oncology +15

Multiple myeloma immunoglobulin lambda translocations portend poor prognosis

Benjamin G. Barwick, Paola Neri, Nizar J. Bahlis et al. · Nature Communications · 2019 · 157 citations · Full text

Medicine, Genetics, Hematology +16

Dexamethasone treatment promotes Bcl-2 dependence in multiple myeloma resulting in sensitivity to venetoclax

Shannon M. Matulis, Vikas A. Gupta, A K Nooka et al. · Leukemia · 2015 · 132 citations

Medicine, Cell Biology, Oncology +13